54Gene
ClosedPrecision medicine for Africans and the global population
Lagos, Nigeria · $44.5M raised
- Headquarters
- Lagos
- Employees
- 11–50
- Website
- 54gene.com
- Total Funding
- $44.5M
- Last Round
- $25.0M Series BSep 2021
- Rounds
- 3
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
We are an African genomics research, services and development company addressing the need to include under-represented African genomic data in research which could lead to medical breakthroughs and new healthcare solutions worldwide.
Summary
54Gene is a Genomics company based in Lagos, Nigeria. It has raised $44.5M in total across 3 rounds, most recently a $25.0M Series B round in Sep 2021. Investors include Cathay Innovation, Adjuvant Capital and Y Combinator.
Tech & App Stack
20 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Sep 2021
Sign up to see all 3 events
Funding: Seed through Series B. Amounts, valuations, and investors where available.
Investors
Similar Companies

Biotechnology company developing multi-cancer early detection blood tests using high-intensity ge...

Provides comprehensive molecular profiling and AI-driven precision oncology services for physicia...
Provides genomic profiling tests and data services to oncologists and biopharma partners to guide...
Ultima Genomics develops high-throughput DNA sequencing platforms that use open-wafer technology ...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/54gene"><img src="https://indexed.vc/api/badge/company/54gene" alt="54Gene on Indexed.vc" width="260" height="76" /></a>

